Schedule 13G ownership disclosure

Stoke Therapeutics Inc

Common Stock · CUSIP: 86150R107

Event date: 2025-06-30

Filing-level shares
3,173,258
Percent of class
5.8%
  • Cowen Financial Products LLC

    Shares: 3,173,258 · Class: 5.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-25-004276
Form type
SCHEDULE 13G/A
Filer
Cowen Financial Products LLC
CIK
CIK 1771015
Filed
Jul 29, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub